Search Results

There are 33353 results for: content related to: Headache Associated With Telaprevir Treatment

  1. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  2. You have free access to this content
    An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

    Hepatology

    Volume 54, Issue 4, October 2011, Pages: 1433–1444, Marc G. Ghany, David R. Nelson, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 26 SEP 2011, DOI: 10.1002/hep.24641

  3. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  4. You have free access to this content
    Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver

    Liver International

    Volume 32, Issue 10, November 2012, Pages: 1477–1492, Vincent Leroy, Lawrence Serfaty, Marc Bourlière, Jean-Pierre Bronowicki, Patrick Delasalle, Alexandre Pariente, Stanislas Pol, Fabien Zoulim and Georges-Philippe Pageaux

    Version of Record online : 14 AUG 2012, DOI: 10.1111/j.1478-3231.2012.02856.x

  5. The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

    Journal of Viral Hepatitis

    Volume 22, Issue 3, March 2015, Pages: 254–262, T. Oze, N. Hiramatsu, T. Yakushijin, R. Yamada, N. Harada, N. Morishita, M. Oshita, E. Mita, T. Ito, Y. Inui, M. Inada, S. Tamura, H. Yoshihara, Y. Imai, M. Kato, T. Miyagi, Y. Yoshida, T. Tatsumi, A. Kasahara, N. Hayashi and T. Takehara

    Version of Record online : 31 JUL 2014, DOI: 10.1111/jvh.12289

  6. Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2090–2099, Patrick Miailhes, Camille Gilbert, Karine Lacombe, Joop E. Arends, Massimo Puoti, Jürgen K. Rockstroh, Philippe Sogni, Hélène Fontaine, Eric Rosenthal, Maria Winnock, Marc-Arthur Loko, Linda Wittkop, François Dabis, Dominique Salmon and the ESCMID European Study Group on Viral Hepatitis

    Version of Record online : 23 FEB 2015, DOI: 10.1111/liv.12799

  7. You have full text access to this OnlineOpen article
    Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patients

    Journal of Gastroenterology and Hepatology

    Volume 31, Issue 1, January 2016, Pages: 14–22, Hiromitsu Kumada, Fumitaka Suzuki, Yoshiyuki Suzuki, Joji Toyota, Yoshiyasu Karino, Kazuaki Chayama, Yoshiiku Kawakami, Shigetoshi Fujiyama, Takayoshi Ito, Yoshito Itoh, Etsuko Tamura, Tomoko Ueki, Hiroki Ishikawa, Wenhua Hu, Fiona McPhee, Misti Linaberry and Eric Hughes

    Version of Record online : 30 DEC 2015, DOI: 10.1111/jgh.13073

  8. Pharmacokinetics of bound and unbound telaprevir in cirrhotic patients with moderate and severe hepatic impairment

    The Journal of Clinical Pharmacology

    Volume 55, Issue 10, October 2015, Pages: 1147–1156, Sivi Ouwerkerk-Mahadevan, Atef Halabi, Blanka Cieslarová, Indra Aerts, James Witek, Rodica Van Solingen-Ristea and Donghan Luo

    Version of Record online : 7 JUL 2015, DOI: 10.1002/jcph.545

  9. Incidence of virological failure and emergence of resistance with twice-daily vs every 8-h administration of telaprevir in the OPTIMIZE study

    Journal of Viral Hepatitis

    Volume 21, Issue 12, December 2014, Pages: 835–842, I. Dierynck, A. Ghys, J. Witek, D. Luo, K. Janssen, B. Daems, G. Picchio, M. Buti and S. De Meyer

    Version of Record online : 17 NOV 2014, DOI: 10.1111/jvh.12347

  10. You have full text access to this OnlineOpen article
    Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 21, Issue 5, May 2014, Pages: 341–347, Y. Karino, I. Ozeki, S. Hige, M. Kimura, T. Arakawa, T. Nakajima, Y. Kuwata, T. Sato, T. Ohmura and J. Toyota

    Version of Record online : 25 AUG 2013, DOI: 10.1111/jvh.12162

  11. Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1165–1171, Kazuto Fukuda, Yasuharu Imai, Naoki Hiramatsu, Keiko Irishio, Takumi Igura, Yoshiyuki Sawai, Sachiyo Kogita, Yuki Makino, Rui Mizumoto, Yasushi Matsumoto, Masanori Nakahara, Sinichiro Zushi, Nobuyuki Kajiwara, Tsugiko Oze, Sumio Kawata, Norio Hayashi and Tetsuo Takehara

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12229

  12. Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon-alpha-2b and ribavirin in hepatitis C patients

    Hepatology Research

    Volume 43, Issue 7, July 2013, Pages: 691–701, Fumitaka Suzuki, Yoshiyuki Suzuki, Hitomi Sezaki, Norio Akuta, Yuya Seko, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saito, Yasuji Arase, Kenji Ikeda, Rie Mineta, Sachiyo Watahiki, Mariko Kobayashi, Yoshiyuki Nakayasu, Hidetaka Tsuda, Keiji Aoki, Ichimaro Yamada and Hiromitsu Kumada

    Version of Record online : 29 NOV 2012, DOI: 10.1111/hepr.12009

  13. The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 2, February 2014, Pages: 185–201, Marina Kawaguchi-Suzuki and Reginald F. Frye

    Version of Record online : 30 SEP 2013, DOI: 10.1002/phar.1349

  14. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  15. You have free access to this content
    Viral Hepatitis

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue S2, October 2013, Pages: 151–177,

    Version of Record online : 10 SEP 2013, DOI: 10.1111/jgh.12365_14

  16. Fatigue-induced changes in tonic vibration response (TVR) in humans: Relationships between electromyographic and biochemical events

    Muscle & Nerve

    Volume 38, Issue 5, November 2008, Pages: 1481–1489, Christelle Brerro-Saby, Stéphane Delliaux, Jean Guillaume Steinberg and Yves Jammes

    Version of Record online : 24 SEP 2008, DOI: 10.1002/mus.21117

  17. You have free access to this content
    Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?

    Hepatology

    Volume 56, Issue 1, July 2012, Pages: 373–381, Alexander J. Thompson and John G. McHutchison

    Version of Record online : 3 JUL 2012, DOI: 10.1002/hep.25792

  18. You have free access to this content
    Development and validation of a “capture-fusion” model to study drug sensitivity of patient-derived hepatitis C

    Hepatology

    Volume 61, Issue 4, April 2015, Pages: 1192–1204, Morven E. Cunningham, Alia Javaid, Jenny Waters, Joseph Davidson-Wright, Joshua L.C. Wong, Meleri Jones and Graham R. Foster

    Version of Record online : 13 FEB 2015, DOI: 10.1002/hep.27570

  19. Effects of hypoxia on muscle response to tendon vibration in humans

    Muscle & Nerve

    Volume 34, Issue 6, December 2006, Pages: 754–761, Stéphane Delliaux and Yves Jammes

    Version of Record online : 29 AUG 2006, DOI: 10.1002/mus.20633

  20. The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice

    Catheterization and Cardiovascular Interventions

    Volume 67, Issue 4, April 2006, Pages: 563–570, Jack L. Martin, Gang Jia, Seth S. Martin, Timothy A. Shapiro, Howard C. Herrmann, Peter M. DiBattiste, Eric J. Topol and David J. Moliterno

    Version of Record online : 12 MAR 2006, DOI: 10.1002/ccd.20622